David M. Euhus, M.D. · Recertified October 19, 2001 and December 16, 2010 (Valid until July 1, 2022) Certificate # 037077 . MILITARY . Department of Surgery Tripler Army Medical

DAVID M. EUHUS, MD CURRICULUM VITAE

OFFICE ADDRESS

University of Texas Southwestern Medical Center 5323 Harry Hines Boulevard Dallas, Texas 75390-8548

OFFICE TELEPHONE 214-648-5890

OFFICE FAX 214-648-1118

E-MAIL [email protected]

SSN Provided upon request

HOME ADDRESS 1020 Village Parkway Coppell, TX 75019

HOME TELEPHONE 972-393-7006

PERSONAL DATA Date of Birth: September 21, 1958 Place of Birth: Sterling, Colorado Wife: Stacy Euhus Children: 4

EDUCATION Saint Louis University School of Medicine St. Louis, MO M.D., 1984 Department of Microbiology Colorado State University Ft. Collins, CO B.S., 1980

INTERNSHIP UCLA Medical Center Los Angeles, CA General Surgery 1984-1985

RESIDENCY Department of Surgery UCLA Medical Center Los Angeles, CA General Surgery 1984-1991

8/20/2012 DAVID M. EUHUS, MD Page 2 of 36

FELLOWSHIP Division of Surgical Oncology

UCLA Medical Center Los Angeles, CA Clinical and Research Fellow 1986-1988

POSTGRADUATE COURSE(S)

American Society of Clinical Oncology Train the Trainer Cancer Genetics Education 1997, 1999 Laparoscopic Skills Enhancement and Suturing Course Sponsored by Yale University: “Topgun” Award Honolulu, HI 1994 Advanced Laparoscopic Surgery Ft. Hood, TX 1993 Advanced Trauma Life Support Instructor Course El Paso, TX 1991 Combat Casualty Care Course (C4) Ft. Sam Houston, TX 1991

LICENSURE Texas – K1428 California – G056247 (inactive)

BOARD CERTIFICATION

The American Board of Surgery, February 12, 1992 Recertified October 19, 2001 and December 16, 2010 (Valid until July 1, 2022) Certificate # 037077

MILITARY Department of Surgery Tripler Army Medical Center Honolulu, HI 1993-1996 Department of Surgery Darnall Army Community Hospital Ft. Hood, TX 1991-1993

ACADEMIC APPOINTMENTS Texas A and M University Medical School, College Station, TX Assistant Clinical Professor of Surgery 1991-1993 Uniformed Services University of the Health Sciences, Bethesda, MD


Clinical Assistant Professor of Surgery 1996 University of Hawaii School of Medicine, Honolulu, HI Clinical Assistant Professor of Surgery 1996 University of Texas Southwestern Medical Center, Dallas, Texas Assistant Professor, Division of Surgical Oncology 1996-2001 University of Texas Southwestern Medical Center, Dallas, Texas Associate Professor, Division of Surgical Oncology 2001 – 2007 University of Texas Southwestern Medical Center, Dallas, Texas Associate Director of Clinical Research Harold C. Simmons Comprehensive Cancer Center 2003 – Present University of Texas Southwestern Medical Center, Dallas, Texas Director of Clinical Cancer Genetics Harold C. Simmons Comprehensive Cancer Center 2007 - Present University of Texas Southwestern Medical Center, Dallas, Texas Professor, Division of Surgical Oncology 2007 - Present HOSPITAL APPOINTMENTS Zale Lipshy University Hospital, Dallas, Texas Staff Surgeon October 1996 - Present Parkland Memorial Hospital, Dallas, Texas Staff Surgeon September 1996 - Present Veterans Administration Medical Center, Dallas, Texas Staff Surgeon September 1996 – Present St. Paul Medical University Hospital, Dallas, Texas 75235 Staff Surgeon March 1997 – Present


ACTIVE GRANTS AND CONTRACTS Department of Defense (DoD BCRP) BC103910 Epigenetic Testing for Breast Cancer Risk Stratification Euhus (PI) 09/30/2011 –09/29/2013 Approved Funding: $537,752 Cancer Prevention Research Institute of Texas (CPRIT) Cancer Genetics Services for Underserved Populations Euhus (PI) 08/31/2011-08/30/2014 Approved Funding: $1,597,535 Foundation for the NIH I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2) Euhus (Institutional PI) 01/24/2011 – 01/24/2013 NIH Cancer Center Support Grant 1 P30 CA142543-01 Willson (PI) 08/03/2010 – 07/31/2015 COMPLETED GRANTS AND CONTRACTS Department of Defense (DoD BCRP) Approved funding: $469,490 2007-2011 Title: Classification of DNA Methylation Patterns in Benign and Malignant Breast Epithelium. Susan G. Komen Breast Cancer Foundation, Inc. Approved funding: $25,000 2006 - 2007 Title: Web-based Breast Cancer Risk Assessment and Counseling Environment. National Institutes of Health/National Cancer Institute (NIH/NCI) Approved funding: $1,200,000 1999-2007 Title: An exploratory study to identify potential surrogate endpoint biomarkers that are modulated by tamoxifen vs. placebo. American Cancer Society Research Scholar Grant Approved funding: $707,000 2001-2006 Title: Markers of Growth Dysregulation in Breast Epithelium from High-risk Women. National Institutes of Health/National Cancer Institute (NIH/NCI) Approved funding: $62,950 1999-2004 Title: Markers for risk assessment/Early detection of lung and breast cancer.


Department of Defense (DoD BCRP) Approved funding: $461,518 2001-2005 Title: Prediction of breast cancer risk by aberrant methylation in mammary duct lavage. Mary Kay Ash Charitable Foundation Approved funding: $100,000 2001-2003 Title: Genotypes Underlying Breast Cancer Susceptibility Phenotypes. Charles Solomon Foundation Approved funding: $75,000 2002-2003 Title: Susceptibility of Breast Epithelial Cells to DNA Damage by Environmental Carcinogens National Institutes of Health (NIH/NIDDK) Approved funding: $37,000 2000-7/31/2007 Title: Mechanisms of lipodystrophy in HIV-infected patients. Summerfield G. Roberts Foundation Approved funding: $48,000 2001-2002 Title: New Approaches for Monitoring and Improving DNA Health. American Society of Clinical Oncology, Career Development Award Approved funding: $170,000 1998-2001 Title: New approaches to molecular risk assessment in breast preneoplasia. Cancer Research Foundation of North Texas Approved funding: $50,000 2000-2001 Title: Clinical study to identify surrogate endpoint biomarkers that are modulated by tamoxifen in women at increased risk for breast cancer. Defense Women’s Health Research Program Approved funding: $90,000 1994-1995 Title: Influence of parenteral progesterone on the prevalence and severity of mastodynia in active duty servicewomen: A multiinstitutional cross-sectional study. ASSOCIATION MEMBERSHIPS Fellow of the American College of Surgeons (FACS) Northern Texas State Chair, Cancer Liaison Program, 2001-2005 Fellow of the Society of Surgical Oncology American Association of Cancer Research American Cancer Society Board of Directors, Honolulu Unit, 1994-1996 Peer Review Committee on Clinical Cancer Research and Epidemiology, 1/2006 - 12/2009


American Society of Breast Disease American Society of Clinical Oncology Association for Academic Surgery Executive Council, 2001 Program Committee, 1999-2000 Society of University Surgeons Susan G. Komen Foundation Study Section Leader, 1999-2001 Breast Cancer Research Projects, 1999-2001 Texas Medical Association Committee on Cancer, 2002-2005 EDITORIAL BOARDS Ad Hoc Reviewer Journal of the National Cancer Institute Cancer Journal of Surgical Research Archives of Surgery Cancer Detection and Prevention International Journal of Cancer Journal of Clinical Oncology Editorial Board Member, The Breast Journal, 2005 – current; Cancer 2007 - current Editorial Advisory Board Member, American Cancer Society, Cancer, February 2006 - February 2009 Contributing Editor, Breast Diseases: A Year Book Quarterly, 2005 - 2006. PERSONAL/PROFESSIONAL RECOGNITION Patents Urinary Tumor Associated Antigen, Antigenic Subunits and Methods of Detection. European Patent No. 00678744 (2000) Software CancerGene http://www4.utsouthwestern.edu/breasthealth/cagene Awards and Honors Phi Delta Epsilon, Colorado State University 1980 Alpha Omega Alpha St. Louis University, School of Medicine 1983 National Research Service Award, Cancer Training Branch, NCI 1986-1988 Clinical Fellowship Award, American Cancer Society


1988 Wilma W. Morton Research Award, UCLA Medical Center 1991 Meritorious Service Medal, U.S. Army 1991 The George and Carol Poston Professorship in Breast Cancer Research, UTSW 1999 - 2003 Marilyn R. Corrigan Distinguished Chair in Breast Cancer Surgery, UTSW 2003 – present COMMITTEES Military Institutional Animal Care and Use Committee, 1993-1995 Tripler Army Medical Center Clinical Investigations Committee, 1993-1995 Tripler Army Medical Center Chairman, Research Committee, General Surgery Division, 1993-1996 Tripler Army Medical Center Chairman, Cancer Committee, 1991 Darnall Army Community Hospital UT Southwestern Medical Center Clinical Information Systems Steering Committee, 1999 - 2010 Clinical Cancer Research Committee, Chairman 2005- present Medical Director Clinical Research Office, 2004 - 2007 Co-Director of the Mary L. Brown Risk Assessment Program, 1999 – present Director, Clinical Cancer Genetics 2008 - present Associate Director of Clinical Research - 2005 - present Protocol Review Monitoring Committee – 2006 Protocol Review Monitoring Committee, Chairman 2009 - present Institutional Review Board – 2009 - 2012 Parkland Hospital System Parkland Cancer Committee, 2005 Medical Director, Breast Oncology Evaluation Clinic, 2000 - 2006


PUBLICATIONS Book Contribution 1. Euhus DM. Commentary Ductal Lavage Findings in Women with Known Breast Cancer Undergoing

Mastectomy. Breast Diseases: A Year Book Quarterly, Volume 17, 2005. 2. Euhus DM. Commentary Ductal Lavage Findings in Women with Mammographic

Microcalcifications Undergoing Biopsy. Breast Diseases: A Year Book Quarterly, Vol. 17(2), 2006. 3. Euhus DM. Commentary Endocrine Biomarkers in Ductal Lavage Samples from Women at High

Risk for Breast Cancer. Breast Diseases: A Year Book Quarterly, Vol. 17(3): 222, 2006. 4. Euhus DM. Commentary Endogenous Sex Hormones, Breast Cancer Risk, and Tamoxifen

Response: An Ancillary Study in the NSABP Breast Cancer Prevention Trial (P-1). Breast Diseases: A Year Book Quarterly, Vol. 17(3), 2006.

5. Euhus DM. Commentary Identification of Biomarkers for Breast Cancer in Nipple Aspiration and

Ductal Lavage Fluid. Breast Diseases: A Year Book Quarterly, Vol. 17(3):225, 2006. 6. Euhus DM. Commentary: Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2

carriers: an update. Breast Diseases: A Year Book Quarterly, Vol. 17(4): 401, 2007.

7. Euhus DM. Breast Disease, Williams Gynecology, McGraw Hill, 2008.

8. Euhus DM. Section Editor. Kuerer’s Breast Surgical Oncology. McGraw-Hill, 2010. a. Section Editor. b. Quantitative Risk Prediction, Chapter 9, pgs. 89-96.

Peer-reviewed Journals 1. Hudd C, Euhus DM, La Regina MC, Herbold DR, Palmer DC, Johnson FE. Effect of

cholecystokinin on human cholangiocarcinoma xenografted into nude mice. Canc Res 1985;45: 1372 - 1377.

2. Euhus DM, Hudd C, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol

1985;31: 229 - 234. 3. Wong JH, Euhus DM, Morton DL. Surgical resection for metastatic melanoma to the lung.

Arch Surg 1988;123: 1091 - 1095. 4. Euhus DM, Wong JH, Gupta RK, Morton DL. Induction of antibody to a tumor associated

antigen by immunization with a whole melanoma vaccine. Cancer Immunol Immunother 1989;29: 247 - 254.

5. Euhus DM, Gupta RK, Morton DL. Detection of a tumor-associated glycoprotein antigen in

serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassay. J Clin Lab Anal 1989;3: 184 - 190.


6. Euhus DM, Gupta RK, Morton DL. Characterization of a 90 - 100 kDa tumor -associated antigen in the sera of melanoma patients. Int J Cancer 1990;45: 1065 - 1070.

7. Euhus DM, Hiatt JH. Management of the acute abdomen complicating oral anticoagulation

therapy. Amer Surg 1990;56: 581 - 586. 8. Euhus DM, Gupta RK, Morton DL. Association between allo-immunoreactive and xeno-

immunoreactive subunits of a glycoprotein tumor-associated antigen. Cancer Immunol and Immunother 1991;32: 214 - 220.

9. Euhus DM, Passaro Jr. E. Scrotal hernia following retropubic prostatectomy. Contemp Surg

1991;39:37 - 40. 10. Euhus DM, Wong JH. Appraisal of anti-idiotypic antibodies in the treatment of human solid

tumors. Surg Gyn Obstet 1992;175:89 - 96. 11. O'Rourke S, Galea M, Morgan D, Euhus D, Pinder S, Ellis IO, Elston CW, Blamey RW.

Local recurrence after simple mastectomy. Br J Surgery 1994; 81: 386-389. 12. Euhus DM. Improved outcome from colorectal cancer in an Army community hospital.

Military Medicine 1997;162:726-728. 13. Euhus DM, Kimura L, Arnold B. Expansion of CD3+CD56+ lymphocytes correlates with

induction of cytotoxicity by IL-2 gene transfer in human breast cancer. Ann Surg Oncol 1997;4:432-439.

14. Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and

severity of mastalgia in premenopausal women. A multi-institutional cross-sectional study. J Amer Coll Surg 1997;184:596-604.

15. Racilla E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LWMM, Uhr JW.

Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci, 1998;95:4589-4594.

16. Nwariaku F, Euhus DM, Beitsch PD, Clifford E, Erdman W, Mathews D, Albores-Saavedra

J, Leitch AM, Peters GN. Sentinel lymph node biopsy: An alternative to elective axillary dissection for breast cancer. Am J Surg 1998;176:529-531.

17. Euhus DM, Maitra A, Wistuba II, Alberts A, Albores-Saavedra J, Gazdar AF. Loss of

heterozygosity at 3p in benign lesions preceding invasive breast cancer. J Surg Res 1999;83(3): 13-18.

18. Euhus DM, Maitra A, Wistuba II, Ashfaq R, Alberts A, Gibbons D, Gazdar AF. Use of

archival fine needle aspirates for the allelotyping of tumors. Cancer Cytopathol 1999;87:372-379.

19. Scott DJ, Bergen PC, Rege RV, Laycock R, Tesfay ST, Valentine RJ, Euhus DM, Jeyarajah

DR, Thompson W, Jones DB. Laparoscopic training on bench models: better and more cost effective than operating room experience? J Am Coll Surg 2000;191:272-283.

20. Wilkenson N, Euhus D. Cyclosporin A does not affect adenoviral-mediated transgene

expression of interleukin-2. Journal of Surgical Investigation 2001;2:491-498.


21. Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M,

Minna JD, Gazdar AF. Loss of expression an aberrant methylation of the CDH13(H-Cahherin) gene in breast and lung carcinomas. Cancer Res 2001;61:4556-4560.

22. Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunningham HT, Farinas

AJ, Milchgrub S, Euhus DM, Gilcrease M, Jerman J, Minna JD, Gazdar AF. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res 2001;1:1998-2004.

23. Dooley WC, Ljung B-M, Veronesi U, Cazzaniga M, Elledge RM, O’Shaughnessy JA, Kuerer

HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SM, Arias RD, Quiring JN, Love SM, Page DL, King EB. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93:1624-1632.

24. Euhus DM. Understanding mathematical models for breast cancer risk assessment and

counseling. The Breast Journal 2001;7:224-232. 25. Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson

GE. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer. J Gynecol Oncol, 2001;83:383-387.

26. Peters GN, Fodera T, Sabol J, Jones S, Euhus D. Estrogen replacement therapy after breast

cancer: A 12-year followup. Ann Surg Oncol 2001;8:828-32. 27. O’Shaughnessy JA, Ljung BM, Dooley WC, Chang J, Kuerer HM, Hung DT, Grant MD,

Khan SA, Phillips RF, Duvall K, Euhus DM, King BL, Anderson BO, Troyan SL, Kim J, Veronesi U, Cazzaniga M. Ductal lavage and clinical management of women at high risk for breast carcinoma: a commentary. Cancer 2002;79:209-15.

28. Euhus DM, Leitch AM, Huth JF, Peters GN. Limitations of the Gail Model in the

specialized breast cancer risk assessment clinic. The Breast Journal 2002;8:23-27. 29. Euhus DM, Peters GN, Leitch AM, Saboorian H, Mathews D, Erdman W, Anglin B, Huth

J. Validating the Performance of the Mammary Sentinel Lymph Node Team. J Surg Oncol, 2002;79:209-15.

30. Euhus DM, Smith KC, Robinson L, Stukey FA, Olopade OI, Cummings S, Garber JE,

Chittenden A, Mills GB, Reiger P, Esserman L, Crawford B, Hughes KS, Roche C, Ganz P, Seldon J, Fabian CJ, Klemp J, Tomlinson G. Pretest Prediction of BRCA1 or BRCA2 Mutation by Risk Counselors and the Computer Program BRCAPRO. J Natl Cancer Inst 2002;94:844-51.

31. Euhus DM, Cler L, Sivapurkar N, Michgrub S, Peters GN, Leitch AM, Heda S, Gazdar AF.

Loss of heterozygosity in benign breast epithelium in relation to breast cancer risk. J Natl Cancer Inst 2002;94:858-60.

32. Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus DM, Morrison L, Tucker

T, Lane N, Ghadimi M, Heselmeyer-Haddad K, Ried T, Rao C, Uhr J. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clinical Cancer Res. 2002;8:2073-84.


33. Euhus DM, Timmons CF, Tomlinson GE. ETV6-NTRK3-Trk-ing the primary event in

human secretory breast cancer. Cancer Cell. 2002 Nov;2(5):347-8. 34. Sakaguchi M, Dudak MW, Virmani A, Peters GN, Leitch AM, Saboorian H, Gazdar AF,

Euhus DM. Clinical relevance of reverse transcriptase polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol. 2003;10(2):117-125.

35. Euhus DM. Cytokeratin staining and other sentinel node controversies. Clin Breast Cancer.

2003 Apr;4 Suppl 1:S49-54. 36. Wilkinson NW, Euhus DM. Adenoviral-mediated gene transfer of interleukin-2 in a human

breast cancer cell line and a fresh primary breast cancer culture. J Invest Surg. 2003 Jul-Aug;16(4):203-8.

37. Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar

A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer. 2003 Aug 20;106(2):198-204.

38. Virmani A, Rathi A, Heda S, Sugio K, Lewis C, Tonk V, Takahashi T, Roth JA, Minna JD,

Euhus DM, Gazdar AF. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. Int J Cancer. 2003 Nov 10;107(3):341-5.

39. Euhus DM. Risk Modeling in Breast Cancer. The Breast Journal. 2004 10(1): S10-S12. 40. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D,

Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LWMM, Fleming T,Fehm T,Tucker T, Lane N, Wang J, Uhr J. HER-2 gene amplification can be acquired as breast cancer progresses. Proceedings of the National Academy of Sciences of the United States of America. June 22, 2004, Vol.101, No. 25, 9393-9398.

41. Maddux AJ, Ashfaq R, Naftalis E, Leitch AM, Hoover S, Euhus D. Patient and Duct

Selection for Nipple Duct Lavage. Am J Surg. 2004 Oct;188(4):390-394. 42. Bu D, Cler L, Lewis C, Euhus D, A Variant of DNA Polymerase-Beta is not Cancer Specific

Journal of Investigative Surgery,17:327-331, 2004. 43. Stadler RF. Gregorcyk SG. Euhus DM. Place RJ. Huber PJ. Simmang CL., Outcome of

HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum. 47(8):1305-9, 2004 Aug.

44. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M,

Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW. Circulating Tumor Cells in Patients with Breast Cancer Dormancy. Clin Cancer Res. 2004 Dec 15;10(24):8152-62.

45. Lewis C, Cler L, Bu D, Zochbauer-Muller S, Milchgrub S, Naftalis E, Leitch AM, Minna J,

Euhus DM. Promoter Hypermethylation in Benign Breast Epithelium in Relation to Predicted Breast Cancer Risk. Clin Cancer Res. 2005 Jan 1;11(1):166-72

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12800194&dopt=Abstract�

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12800194&dopt=Abstract�

http://gateway.ut.ovid.com/gw1/ovidweb.cgi?S=IDNJHKOALFPJKM00D&Search+Link=%22Stadler+RF%22.au.�

http://gateway.ut.ovid.com/gw1/ovidweb.cgi?S=IDNJHKOALFPJKM00D&Search+Link=%22Gregorcyk+SG%22.au.�

http://gateway.ut.ovid.com/gw1/ovidweb.cgi?S=IDNJHKOALFPJKM00D&Search+Link=%22Euhus+DM%22.au.�

http://gateway.ut.ovid.com/gw1/ovidweb.cgi?S=IDNJHKOALFPJKM00D&Search+Link=%22Place+RJ%22.au.�

http://gateway.ut.ovid.com/gw1/ovidweb.cgi?S=IDNJHKOALFPJKM00D&Search+Link=%22Huber+PJ%22.au.�

http://gateway.ut.ovid.com/gw1/ovidweb.cgi?S=IDNJHKOALFPJKM00D&Search+Link=%22Simmang+CL%22.au.�

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15623589�




46. Maddux AJ, Ashfaq R, Naftalis E, Leitch AM, Hoover S, Euhus DM. Reproducibility of

Cytological Atypia in Repeat Nipple Duct Lavage. Cancer. 2005 Mar 15;103(6):1129-36. 47. Patterson A, Davis H, Euhus D, Neuhausen S, Strong L, Tomlinson G.. Recruitment for

Breast Cancer Predisposition Studies in an Underserved African-American Population. Breast J. 2005 Jan-Feb;11(1):79-82.

48. Coyle Y, Minhajuddin A, Euhus D, Hynan L. An Ecological Study of the Association of

Environmental Chemicals on Breast Cancer Incidence in Texas. Breast Cancer Research and Treatment. 2005 Jul;92(2):107-14.

49. Euhus DM. Clinical Relevance of Circulating Tumor Cells in the Management of Breast

Cancer. Biological Therapy of Breast Cancer, November 2005, Vol. 6, No. 3. 50. Chen S, Iversen ES, Friebel T, Finkelstein, Weber B, Eisen A, Peterson L, Schildkraut JM,

Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G. Characterization of BRCA1 and BRCA2 Mutations in a Large US Sample. Journal of Clinical Oncology, February 2006, 24(6):863-71.

51. Cler L, Bu D-w, Lewis C, Euhus DM, A comparison of five methods for extracting DNA

from paucicellular clinical samples. Molecular and Cellular Probes. June-August 2006, 20(3-4):191-196.

52. Euhus DM. Breast Cancer Prevention in the 21st Century -- Defining the Challenge, The

Breast Journal, March/April 2006, 12 (2):97-98. 53. Lewis C, Herbert B-S, Bu D, Halloway S, Beck A, Shadeo A, Zhang C, Ashfaq R, Shay JW,

Euhus DM. Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier. Breast Cancer Research and Treatment, September 2006, 99(1):103-115.

54. Zhang C, Naftalis E, Euhus DM. Carcinogen-induced DNA Double Strand Break Repair in

Sporadic Breast Cancer. Journal of Surgical Research, September 2006, 135(1):120-128. 55. Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM. An Intronic

Polymorphism Associated with Increased XRCC1 Expression, Reduced Apoptosis and Familial Breast Cancer. Breast Cancer Research and Treatment, October 2006, 99(3):257-265.

56. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber S, Euhus DM,

Kinzler K, Jass J, Gallinger S, Lindor N, Casey G, Ellis N, Giardiello F, Offit K, Parmigiani G. Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome. Journal of the American Medical Association, September 26, 2006, 296(12):1479-1487.

57. Shames DS, Girard L, Gao B, Sato M, Jian A Shyr Y, Fong K, Gerald W, Pollack JR, Perou

CM, Gazdar AF, Euhus DM, Shay JS, Minna JD. A Genome-wide Screen for Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies. PLoS Medicine, December, 2006, 3(12):e486.


58. Coyle YM, Xie X-J, Lewis CM, Bu D, Milchgrub S, Euhus DM. Role of Physical Activity in Modulating Breast Cancer Risk as Defined by APC and RASSF1A Promoter Hypermethylation in Nonmalignant Breast Tissue. Cancer Epidemiol Biomark Prev February, 2007, 16(2): 192-196.

59. Bushnaq Z, Ashfaq R, Leitch AM, Euhus D. Patient Variables That Predict Atypical

Cytology by Nipple Duct Lavage, Cancer, April 2007, 109(7): 1247-1254. 60. Chen S, Euhus D, M.D., Parmigiani G, .Quantitative Models for Predicting Mutations in

Lynch Syndrome Genes, Current Colorectal Cancer Reports. October 2007, 3(4): 206-211. 61. Ma AM, Bowling M, Leitch M, Rao R, Euhus D. Primary breast tumor characteristics

predicting aggressive nodal involvement. Am J Surg, October 2007, 194(4): 474-476. 62. Euhus D, Bu D, Ashfaq R, Xie X, Bian A, Leitch M, Lewis C. Atypia and DNA Methylation

in Nipple Duct Lavage in Relation to Predicted Breast Cancer Risk, Cancer Epidemiology Biomarkers and Prevention. September 2007, 16(9):1812-1821.

63. Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM. Validity of Models for Predicting BRCA1 and BRCA2 Mutations. Annals of Internal Medicine, October 2007; 147:441-450.

64. Gao, B, Xie, XJ, Huang, C., Shames, D., Chen, T., Lewis, C., Bian, A., Zhang, B., Olopade,

O., Garber, J., Euhus D, Tomlinson, G., Minna, J. RASSF1A Polymorphism A133S Is Associated With Early Onset Breast Cancer In BRCA 1/2 Mutation Carriers, Cancer Research, 2008; 68:22-25.

65. Euhus D, Bu D, Milchgrub, S., Xie X, Bian A, Leitch M, Lewis C. DNA Methylation in

Benign Breast Epithelium in Relation to Age and Breast Cancer Risk, Cancer Epidemiology Biomarkers and Prevention, 2008;17:1051 -1059.

66. Murphy CD, Lee JM, Drohan B, Euhus D, Kopans DB, Gadd MA, Rafferty EA, Specht MA,

Smith BL, Hughes KS. The American Cancer Society Guidelines for Breast Screening with MRI: An Argument for Genetic Testing. Cancer; In Press.

67. Hill V, Hesson L, Dansranjavin T, Dallol A, Bieche I, Vacher S, Tommasi S, Dobbins T, Gentle D, Euhus D, Lewis C, Dammann R, Ward R, Minna J, Maher E, Pfeifer G, Latif F. Identification of 5 novel genes methylated in breast and other epithelial cancers. Molecular Cancer 2010, 9:51.

68. Rao R, Moldrem A, Sarode V, White J, Amen M, Rao M, Andrews V, Euhus D, Radford L,

Ulissey M. Experience with Seed Localization for Nonpalpable Breast Lesions in a Public Health Care System. Ann Surg Oncol 2010.

69. Brazda A. Estroff J. Euhus D. Leitch A.M. Huth J. Andrews V. Moldrem A. Rao R. Delays

in Time to Treatment and Survival Impact in Breast Cancer. Ann Surg Oncol 2010; 17:291-

70. Euhus D. Managing the Breast in Patients Who Test Positive for Hereditary Breast Cancer. Ann Surg Oncol. 2012 Mar 7. [Epub ahead of print] PubMed PMID:

22395981.


71. Euhus, David M. New Insights Into the Prevention and Treatment of Familial Breast Cancer, Journal of Surgical Oncology, 2011; 103: 294-298.

72. Euhus D, Bu D-w, Xie X-J, Sarode V, Ashfaq R, Hunt K, Xia W, O’Shaughnessy J, Grant M, Arun B, Dooley W, Miller A, Flockhart D, Lewis C. Tamoxifen Downregulates Ets-oncogene Family Members ETV4 and ETV5 in Benign Breast Tissue: Implications for Durable Risk Reduction. Cancer Prev Res 2011; e-published July 21, 2011.

73. Park, Jiyoung, Euhus, David M. and Scherer, Philipp E. Paracrine and Endocrine Effects of Adipose

Tissue on Cancer Development and Progression. Endocrine Reviews, August, 2011: 32(4).

74. Euhus D. Managing the Breast in Patients Who Test Positive for Hereditary Breast Cancer. Ann Surg Oncol. 2012 Mar 7. PubMed PMID: 22395981.

75. Masciari S, Dillon DA, Rath M, Robson M, Weitzel JN, Balmana J, Gruber SB, Ford JM, Euhus D, Lebensohn A, Telli M, Pochebit SM, Lypas G, Garber JE. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat. 2012 Mar 4. PubMed PMID: 22392042. 76. Lewis CM, Bu D, Sarode V, Robinson L, Wilson K, Viscusi RK, Eng C, Euhus DM. The clinical

consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome. Breast Cancer Res Treat. 2012;132(3):911-918.

77. Park J, Sarode V, Euhus D, Kittler R, Scherer P. Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer. Proceedings National Academy of Sciences, USA. Epub December 3, 2012.

78. Euhus DM, Robinson L. Genetic Predisposition Syndromes and Their Management. Surgical Clinics

of North America. 2012, in press. 79. Bu D, Lewis CM, Sarode V, Chen M, Ma X, Lazorwitz AM, Rao R, Leitch M, Moldrem A, Andrews

V, Gazdar A, Euhus D. Identification of Breast Cancer DNA Methylation Markers Optimized for Fine Needle Aspiration Samples. Cancer Research 2012, under review.

LECTURES AND PRESENTATIONS 1. The Breast Lump. Family Practice Educational Program, UT Southwestern Medical Center,

Dallas, TX, 1998. 2. Measuring Breast Cancer Risk. Cancer Genetics for Clinicians, UT Southwestern Medical

Center, Dallas, TX, 1998. 3. Cost Effective Follow-up for Breast Cancer. UT Southwestern Medical Center Breast

Symposium, Dallas, TX, 1998. 4. Cancer Genetics for Surgeons. Current Topics in General Surgery, UT Southwestern

Medical Center, Dallas, TX, 1999.


5. Measuring Breast Cancer Risk. Cancer Genetics for Clinicians, UT Southwestern Medical Center, Dallas, TX, 1999.

6. Breast Cancer Risk Assessment and Intervention. Wendy Reves Symposium, UT

Southwestern Medical Center, Dallas, TX 1999. 7. Sentinel Lymph Node Biopsy for Breast Cancer. Texas Medical Association Annual

Meeting, Austin, TX, 1999. 8. Sentinel Lymph Node Biopsy for Breast Cancer. Physicians Assistants National Program,

Dallas, TX, 1999. 9. Sentinel Lymph Node biopsy for Breast Cancer. Tyler Breast Cancer Symposium, Tyler,

TX, 1999. 10. Breast Cancer Risk Assessment and Intervention. Blue Cross Blue Shield Employee

Education Program, Dallas, TX, 1999. 11. Measuring Breast Cancer Risk. Southwestern Foundation Symposium, 1999. 12. Sentinel Lymph Node Biopsy for Breast Cancer. Arizona Chapter American College of

Surgeons, Phoenix, AZ, 1999. 13. Breast Cancer in Pregnancy. Arizona Chapter American College of Surgeons, Phoenix, AZ,

1999. 14. Measuring Breast Cancer Risk. Arizona Chapter American College of Surgeons, Phoenix,

AZ, 1999. 15. Recent Advances in Breast Cancer Research. Komen Foundation National Affiliates

Meeting, Dallas, TX, 2000. 16. Minimally Invasive Breast Surgery: How Little is Too Little? Tyler Breast Cancer

Symposium, Tyler, TX, 2000. 17. Breast Cancer Development: The Earliest Markers of Initiation and Promotion. American

Society of Investigational Pathologists, Postgraduate Course in Neoplasia at the FASEB meeting, San Diego, CA, 2000.

18. Common Breast Disorders. Nurse Midwife Program, Parkland Health and Hospital System,

2000. 19. Breast Cancer Prevention. American College of Surgeons Spring Meeting, Washington,

D.C., 2000. 20. Breast Cancer Treatment in the New Millennium. Plastic Surgery Grand Rounds, UT

Southwestern Medical Center, Dallas, TX, 2000. 21. Breast Ultrasound for the Surgeon. Current Topics in General Surgery, UT Southwestern

Medical Center, Dallas, TX 2000. 22. Breast Cancer Risk Measurement and Intervention, San Angelo, TX, August 2000.


23. Genes, Probability and Breast Cancer: Improving the Odds. Presbyterian Hospital, Plano, TX, September 2000.

24. Breast Cancer Risk Measurement and Intervention. American Academy of Procedural

Coders. Dallas, TX, September 2000. 25. Breast Cancer Prevention. Department of Surgery Grand Rounds, UT Southwestern

Medical Center, Dallas, TX, October 2000. 26. Breast Cancer Prevention. Capital Surgeons Symposium, Austin, TX, November 2000. 27. Breast Cancer Genetics. Capital Surgeons Symposium, Austin, TX, November 2000. 28. Breast Cancer Risk Assessment. 6th Annual Breast Care Advances, UT Southwestern

Medical Center, Dallas, TX, December 2000. 29. Breast Cancer: Truth and Fallacies. Hackberry Creek Woman’s Club, Dallas, TX, January

2001. 30. Genes, Probability and Breast Cancer: Improving the Odds. Presbyterian Hospital, Dallas,

TX, January 2001. 31. Comparison of Mathematical Models for Breast Cancer Risk Assessment. Wendy Reeves

Symposium, Dallas, TX, February 2001. 32. Breast Cancer Prevention. First Annual Komen Foundation Lecture, Fort Worth Surgical

Society, April 2001. 33. Loss of Heterozygosity in Benign Breast Epithelium in Relation to Cytological

Abnormalities and Breast Cancer Risk, American Cancer Society Science Writers Symposium, Dana Point, CA, April 2001.

34. Breast Cancer Prevention. Current Topics in General Surgery, UT Southwestern Medical

Center, Dallas, TX, May 2001. 35. Breast Cancer Genetics. Arlington Memorial Hospital, Arlington, TX, October 2001. 36. Breast Cancer Genetics. Breast Cancer Symposium, UT Austin, October 2001. 37. Lifestyle Changes for Breast Cancer Risk Reduction, 7th Annual Breast Care Advances,

Dallas, TX, October 200l. 38. Techniques for Risk Assessment in Breast Cancer: A) Ductal Lavage, B) Computer

Models, C) Fine Needle Aspiration. 7th Annual Breast Care Advances, Dallas, TX, October 2001.

39. Measuring Breast Cancer Risk. Covenant Medical Surgical Conference, Lubbock, TX,

October 2001. 40. The Breast Lump. Covenant Medical Surgical Conference, Lubbock, TX, October 2001. 41. Genes, Probability and Cancer: Improving the Odds. Texas Tech University, Lubbock, TX,

November 2001.


42. Genes, Probability and Cancer: Improving the Odds. Presbyterian Hospital, Dallas, TX,

November 2001. 43. Understanding Models for Breast Cancer Risk Assessment. National Association of Breast

Centers, Las Vegas, NV, March 2002. 44. Impact of Hormone Replacement and Breast Cancer Risk. 5th Annual Tyler Breast

Conference, Tyler, TX, March 2002. 45. Alternative to Hormone Replacement Treatment. 5th Annual Tyler Breast Conference,

Tyler, TX, March 2002. 46. Genetic Evaluation for Cancer. Las Palmas Medical Center, El Paso, TX, April 2002. 47. Genetic Counseling. Amarillo Cancer Center, Amarillo, TX, April 2002. 48. Genes, Probability and Breast Cancer: Improving the Odds. Texas Medical Association,

Dallas, TX, April 2002. 49. Lymphatic Mapping & Sentinel Lymph Node Biopsy in Breast Cancer and Melanoma. UT

Southwestern Medical Center, Dallas, TX, May 2002. 50. Measuring Breast Cancer Risk. Asian Indian Conference, Ft. Worth, TX, July 2002. 51. Genetic Instability & Other Molecular Markers of Increased Risk. International Breast

Congress, Bahamas, August 2002. 52. Genetic Evaluation for Cancer. Austin Society of Internal Medicine, Austin, TX,

September 2002. 53. Genetic Susceptibility Testing for Breast & Ovarian Cancer. Alexian Brothers Medical

Center, Chicago, IL, September 2002. 54. Markers of Growth Dysregulation in Breast epithelium from High Risk Women. American

Cancer Society Board of Directors, Austin, TX, September 2002. 55. Non-Hormonal Options for the Treatment of Menopausal Symptoms, 8th annual Breast

Care Advances for the Primary Care Practitioner, Dallas, TX, October 2002. 56. Managing Post-menopausal Symptoms in Breast Cancer Survivors. 6th Annual Fall

Oncology Conference: Advances in Solid Tumors, Hilton Head, SL, October 2002. 57. Timing and Type of Breast Reconstruction. Emerging Trends in Adjuvant Therapy of

Breast Cancer, New York, NY, October 2002. 58. Sentinel Lymph Node Biopsy and Cytokeratin Staining. Emerging Trends in Adjuvant

Therapy of Breast Cancer, New York, NY, October 2002. 59. Understanding Mathematical Models for Breast Cancer Risk Assessment. Lynn Sage

Symposium, Chicago, IL October 2002.


60. Prevention of Breast Cancer. Global Congress of Gynecologic Endoscopy, Miami Beach, FL, November 2002.

61. Objective Methods of Breast Cancer Risk Assessment: Computer Models and Nipple Duct

Lavage. Global Congress of Gynecologic Endoscopy, Miami Beach, FL, November 2002. 62. Genetic Evaluation for Breast Cancer. Physician Oncology Education program 2nd Annual

Breast Cancer Symposium, Austin, TX, December 2002. 63. BRCA Genes: New and Important Findings for Ashkenazi Women. Maimonides Society,

Jewish Federation of Greater Dallas, Dallas, TX, December 2002. 64. Genes, Probability & Breast Cancer – Improving the Odds. Department of Surgery Grand

Rounds, UT Southwestern Medical Center, Dallas, TX, February 2003. 65. Genes, Probability & Breast Cancer - Improving the Odds. North Texas Chapter of

American College of Surgeons, Dallas, TX, February 2003. 66. Genetic Evaluation for Cancer, African American Breast Cancer Summit, Dallas, TX,

March 2003. 67. BRCA Genetic Testing: Implications for the Surgical Oncologist. Society of Surgical

Oncology, Los Angeles, CA, March 2003. 68. Hormone Replacement, Promise or Poison: Results from the Women’s Health Initiative. 6th

Annual Tyler Breast Conference, Tyler, TX, March 2003. 69. Controversy in Sentinel Lymph Node Biopsy. 6th Annual Tyler Breast Conference, Tyler,

TX, March 2003. 70. Timing and Type of Breast Cancer Reconstruction. 6th Annual Tyler Breast Conference,

Tyler, TX, March 2003. 71. Risk Modeling Using Different Outcome and Consortium Databases. Annual Symposium,

American Society of Breast Disease, Dallas, TX, April 2003. 72. Breast Risk Assessment. Cancer Research Foundation of North Texas Women’s Auxiliary,

Arlington, TX, May 2003. 73. Screening for High Risk Breast Cancer. Current Topics in General Surgery, UT

Southwestern Medical Center, Dallas, TX, May 2003. 74. Controversies in Sentinel Node Biopsy. CME, Austin, TX, May 2003. 75. Breast Carcinogenesis: Focus on DNA Repair & Methylation. Second Annual Future of

Breast Cancer Congress, Banff, Canada, July 2003. 76. Molecular Abnormalities in Breast Intraepithelial Neoplasia. Second Annual Future of

Breast Cancer Congress, Banff, Canada, July 2003. 77. Implementing Risk Assessment: Changing the Breast Risk Paradigm, Medical Education

Program, Dallas, TX, September 2003.


78. Surgical Management of Breast Cancer in the Neoadjuvant Setting. American Society of Breast Disease Education Program, Dallas, TX, October 2003.

79. Sentinel Lymph Node Controversies. Emerging Trends in Adjuvant Therapy of Breast

Cancer, New York, NY, Oct. 2003. 80. Therapy of Rare Breast Cancers. Emerging Trends in Adjuvant Therapy of Breast Cancer,

New York, NY, October 2003. 81. Management of Rare Breast Cancers and Benign Breast Conditions. School of Breast

Oncology, Emory University, Atlanta, GA, November 2003. 82. Breast Cancer Screening. Wilson N. Jones Medical Center CME program, Sherman, TX,

January 2004. 83. Nipple Duct Discharge: Clinical Management & Implications for Breast Cancer Risk

Stratification, Society of Gynecologic Oncologist, San Diego, CA, February 2004. 84. Surgical Management of Early Breast Cancer. Society of Gynecologic Oncologist, San

Diego, CA, February 2004. 85. Current Management of Ductal Carcinoma in situ.. Society of Gynecologic Oncologist, San

Diego, CA, February 2004. 86. “AJCC TNM Staging” An Essential Component in Providing Quality Cancer Care, United

Regional Healthcare System, Wichita Falls, TX, March 2004. 87. Update on the Management of Inflammatory Breast Carcinoma. 7th Annual Tyler Breast

Conference 2004, Tyler, TX, March 2004. 88. Prophylactic Mastectomy and Oophorectomy in High Risk Women with History of Breast

Cell Carcinoma or Strong Family History of Breast Cell Carcinoma. 7th Annual Tyler Breast Conference 2004, Tyler, TX, March 2004.

89. Genetic Evaluation for Cancer. POEP & Ector County Medical Society, Odessa, TX,

March 2004. 90. Update on Breast Cancer Screening. Texas Association of OB/GYN (TAOG), Dallas, TX,

April 2004. 91. Breast Cancer. Cancer Biology Course, UT Southwestern Medical Center at Dallas, Dallas,

TX, April 2004. 92. Clinical Trial Design. Cancer Biology Course, UT Southwestern Medical Center at Dallas,

Dallas, TX, May 2004. 93. Breast Cancer Screening 2004: What Every Surgeon Should Know. Current Topics in

General Surgery 2004, UTSWMC, Dallas, TX, May 2004. 94. Moderator for Breakout 3: Risk Assessment. NCI Cancer Risk Workshop. Washington,

DC, May 2004.


95. Breast Cancer Risk Assessment for the General Surgeon. Parkland Surgical Society, Dallas, TX, June 2004.

96. New Insights Into Inflammatory Breast Cancer. 3rd Annual Future of Breast Cancer: An

International Congress. Hamilton, Bermuda, July 2004. 97. Surgical Implications of Genetic Testing. 90th Annual American College of Surgeons

Clinical Congress, New Orleans, LA, Oct 2004. 98. Sentinel Node Controversies. Controversies in Breast Cancer Adjuvant and Neoadjuvant

Therapy:2004, New York, NY, Oct 2004. 99. Inflammatory Breast Cancer. Controversies in Breast Cancer Adjuvant and Neoadjuvant

Therapy:2004, New York, NY, Oct 2004. 100. Hereditary Cancer Syndromes. University of Arkansas for Medical Sciences Grand

Rounds, Texarkana, AR, Oct 2004. 101. Biology of Breast Carcinogenesis and Key Biologic Pathways. School of Breast Oncology,

Atlanta, GA, Nov 2004. 102. Management of Rare and Male Breast Cancer and Benign Breast Conditions. School of

Breast Oncology, Atlanta GA, Nov 2004. 103. New Insights into Sentinel Lymph Node Biopsy. Current Trends in Breast Cancer, Updates

from the 2004 San Antonio Breast Cancer Symposium, Houston, TX, Jan 2005. 104. New Insights into Sentinel Lymph Node Biopsy. Current Trends in Breast Cancer, Updates

from the 2004 San Antonio Breast Cancer Symposium, Seattle, WA, Jan 2005. 105. New Insights into Sentinel Lymph Node Biopsy. Current Trends in Breast Cancer, Updates

from the 2004 San Antonio Breast Cancer Symposium, Washington DC, Jan 2005. 106. New Insights into Sentinel Lymph Node Biopsy. Current Trends in Breast Cancer, Updates

from the 2004 San Antonio Breast Cancer Symposium, Greenwich, CT., February 2005. 107. Surgical Advances in Cases of Genetic Predisposition. New Frontiers in Breast Cancer,

Wendy and Emory Reves Symposium, Dallas TX., February 2005. 108. Surgical Implications of Genetic Testing, 2005 Breast Cancer Challenge, Ridgedale, MO.,

February 2005. 109. University of Iowa, Dept of Surgery Grand Rounds, Iowa City, IA., February 2005. 110. Managing Hereditary Non-polyposis Colon Cancer Families, North TX Chapter of

American College of Surgeons, Dallas, TX. February 2005. 111. Breast Cancer Screening & Risk Reduction, Early Detection & Prevention of Cancer course

(Med1036) UT Southwestern, Dallas, March 2005. 112. Ductal Lavage and Ductoscopy: The Fantastic Voyage, 8th Annual Tyler Breast

Conference, Tyler, TX, March 2005.


113. Management of Rare Breast Cancer and Benign Breast Conditions, 8th Annual Tyler Breast Conference, Tyler, TX, March 2005.

114. Inherited Predisposition Syndromes, American Society of Breast Surgeons 6th Annual

Meeting, Los Angeles, CA, March 2005. 115. Atypia in NAF and Non NAF Ducts, 4th International Conference on the Intraductal

Approach to the Breast, Santa Barbara, CA, March 2005. 116. Current Management of High Risk Breast Pre-Neoplasia and DCIS, Current Topics in

General Surgery, UTSWMC, Dallas, TX, April 2005. 117. Genetic Evaluation of Cancer, Texas Academy of Family Physicians Spring Conference,

Amarillo, TX, April 2005. 118. Molecular Carcinogenesis and Progression: Therapeutic Implications, 4th International

Future of Breast Cancer Congress, Southampton, Bermuda, July 2005. 119. Breast Disorders. UT Southwestern Medical Center, Department of Physician Assistant

Studies, Dallas, TX, July 20, 2005. 120. Adjuvant Treatment Implications of Breast Cancer. Adjuvant and Neoadjuvant Therapy

2005, Controversies in Breast Cancer, New York, New York, September 11, 2005. 121. Breast Cancer Surgery. Santa Engracia Hospital 9th Anniversary CME Program,

Monterrey, Mexico, September 23, 2005. 122. Sentinel Node Questions. Santa Engracia Hospital 9th Anniversary CME Program,

Monterrey, Mexico, September 23, 2005. 123. Biology of Breast Carcinogenesis and Key Biologic Pathways. School of Breast Oncology,

Atlanta, GA, November 10, 2005. 124. Management of Rare and Male Breast Cancers & Benign Breast Conditions. School of

Breast Oncology, Atlanta, GA, November 11, 2005. 125. Growth Factor Signaling: From Stem Cells to Cancer. 9th Annual Tyler Breast Cancer

Conference 2006, Tyler, TX, February 11, 2006. 126. Who Needs Axillary Lymph Node Dissection? 9th Annual Tyler Breast Cancer Conference

2006, Tyler, TX, February 11, 2006. 127. Genetic Risk assessment for Cancer -- Does it Matter? Massachusetts General Hospital

Breast Rounds, Boston, MA, February 28, 2006. 128. An Overview of Breast and Ovarian Cancer Genetics: What are the Known Genes Causing

Breast Cancer Susceptibility and How Do They Work? National Consortium of Breast Centers 16th National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 11, 2006.

129. Using the Models to Assess Risk. National Consortium of Breast Centers 16th National

Interdisciplinary Breast Center Conference, Las Vegas, NV, March 11 and 12, 2006.


130. Identifying High Risk Patients: You Can't Help Them Unless You Know Who They Are. 16th National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 12, 2006.

131. Identification and Management of the High Risk Patient. American Society of Breast

Disease, 30 Anniversary Symposium, Las Vegas, NV, April 28, 2006. 132. Sentinel Lymph Node Controversies. Controversies in Breast Cancer: Adjuvant and

Neoadjuvant Therapy 2006, New York, NY, September 8, 2006. 133. Breast Cancer Risk Assessment, Surgery Grand Rounds, UT Southwestern Medical Center

at Dallas, October 25, 2006. 134. New Insights into Optimizing Local Control, Current Trends in Breast Cancer, New York,

NY, January 13, 2007. 135. Genetic Evaluation of Cancer, Medical Center of Plano, Plano, TX, January 25, 2007. 136. New Insights into Optimizing Local Control, Current Trends in Breast Cancer,

Washington, DC, January 27, 2007. 137. Surgery Research Conference, UT Southwestern Medical Center, Dallas, TX, February 7,

2007. 138. Who is at Risk and Why, Risk Assessment and Tailoring of Screening and Prevention,

Wendy and Emery Reves International Biennial Breast Cancer Symposium, Dallas, TX, February 10, 2007.

139. Surgical Considerations in Patients Receiving Preoperative Therapy, 10th Annual Tyler

Breast Cancer Conference, Tyler, TX, February 10, 2007. 140. New Insights into Optimizing Local Control, Current Trends in Breast Cancer, Denver, CO,

February 17, 2007. 141. Principles of Cancer Genetics: Biology Visits the Clinic, National Consortium of Breast

Centers 17th Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, February 24, 2007.

142. Familial Breast Cancer: Know Your Genes, National Consortium of Breast Centers 17th

Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, February 24, 2007.

143. Dallas-Fort Worth Area Genetic Counselors Meeting, Dallas, TX, February 27, 2007. 144. Update on Hereditary Colon Cancer, Moncrief Cancer Resources, Fort Worth, TX, March

21, 2007. 145. Advances in Breast Cancer Therapy, Southern Society of Clinical Surgeons, Dallas, TX,

April 2, 2007. 146. Internal Medicine Grand Rounds, UT Southwestern Medical Center, "Colon Cancer

Genetics", Dallas, TX, April 19, 2007.


147. Managing Women at High-Risk for Breast Cancer, Current Topics in General Surgery, UT Southwestern Medical Center, Dallas, TX, May 4, 2007.

148. Tumor Suppressor Gene Methylation: A reversible biomarker of breast cancer risk?,

Massachusetts General Hospital Breast Grand Rounds, Boston, MA, June 2007. 149. Sixth Annual International Congress on the Future of Breast Cancer: Optimizing the

Diagnosis and Treatment of Breast Cancer Subtypes, “Best of Breast Cancer Biologic Research: 2006-2007”, Kona, HI, July 2007.

150. Roswell Park Cancer Institute Surgical Oncology's Core Curriculum/Grand Rounds Lecture

Series. "Surgical Issues in Inherited Cancer Syndromes." Buffalo, NY, September 2007. 151. Explaining the Unexplainable: BRCA1 & BRCA2 Negative Results in the Context of

Suspicious Personal/Family History of Breast Cancer, UT Southwestern/Continuing Medical Education, Fort Worth, TX, October 3, 2007.

152. Genetic and Epigenetic Alterations in Breast Carcinogenesis, Controversies in Breast

Cancer: Adjuvant and Neoadjuvant Therapy 2007, New York, NY, October 12, 2007. 153. Surgical Controversies in Breast Cancer, New Developments in Breast Cancer, Houston,

TX, November 3, 2007. 154. Biology of Breast Carcinogenesis and Key Biologic Pathways, 2007 School of Breast

Oncology, Atlanta, GA, November 8, 2007. 155. New Insights into Optimizing Local Control, Current Trends in Breast Cancer, Boston,

MA, January 19, 2008. 156. Genetic Testing for Urological, Gynecological, Endocrine and Pediatric Cancer, Simmons

Comprehensive Cancer Center and The Office of Continuing Education at The University of Texas Southwestern Medical Center at Dallas, Fort Worth, TX, January 30, 2008.

157. New Insights into Optimizing Local Control, Current Trends in Breast Cancer, San Juan,

PR, February 9, 2008. 158. Overview of Hereditary Cancer Genetics; Quantitative Risk Assessment: The Models. 18th

Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 1-5, 2008.

159. Cancer Genetics: The State-of-the-Art of Surgical Benefits and Management Options,

Moncrief Cancer Resources and UT Southwestern Medical Center CME DVD, March 2008.

160. New Insights into Optimizing Local Control, Current Trends in Breast Cancer,

Minneapolis, MN, March 8, 2008. 161. Nipple Preserving Mastectomy; Clinical Utility of Circulating Tumor Cells, 11th Annual

Tyler Breast Cancer Conference, Tyler, TX, March 28 and 29, 2008. 162. Breast Health and Cancer Screening in HIV Positive Women, 5th Women and HIV

International Clinical Conference, Dallas, TX, April 29, 2008.


163. Current Topics in General Surgery, "Surgical Issues in Inherited Cancer Syndromes", UT Southwestern Medical Center, Dallas, TX, May 2, 2008.

164. Massachusetts General Hospital Breast Grand Rounds. Multidisciplinary Breast Rounds, Boston, MA, May 2008.

165. Seventh International Congress on the Future of Breast Cancer, Nipple-Sparing

Mastectomy, Koloa, HI, July 2008.

166. NCI: Strategic Discussion on Biomarkers for Breast Cancer, “DNA Methylation in Benign Breast Epithelium Tissue in Relation to Age and Breast Cancer Risk,” Seattle, WA, September 2008.

167. National Society of Genetic Counselors, Model Magic: How to Select and Utilize the Risk Models in Clinical Care, Los Angeles, CA, October 27, 2008.

168. Komen Memorial Lecture @ Fort Worth Surgical Society, “Update Breast Cancer Genetics

and Biology”, Fort Worth, TX, November 2008.

169. Breast Cancer Family Registry: The 2nd Scientific Conference on Familial Aspects of Breast Cancer, San Antonio, TX, December 10, 2008.

170. “New Insights Into Surgical and Radiation Therapies”, Current Trends in Breast Cancer, Seattle, WA, January 10, 2009.

171. “New Insights Into Surgical and Radiation Therapies”, Current Trends in Breast Cancer, Dallas, TX, January 17, 2009

172. “New Insights Into Surgical and Radiation Therapies”, Current Trends in Breast Cancer, Richmond, VA, January 31, 2009.

173. Course Director, International Biennial Breast Cancer Symposium, Wendy and Emory Reves Symposium, Dallas TX, February 2009.

174. Capra Research Symposium, Perspectives on the Diagnosis and Treatment of Cancer, “Energy Balance and Cancer”, March 3, 2009.

175. Overview of Hereditary Cancer Genetics; Management of Breast Cancer Risk; Clinical Management: Challenging Cases/Ask the Experts. 19th Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 14-15, 2009.

176. An Introduction to Breast Cancer Genetics, Moncrief Cancer Resources Breast Cancer Symposium, Fort Worth, TX, April 9, 2009.

177. Can You Change Your Risk: The Link Between Diet and Cancer, Friends for Comprehensive Cancer Care and Research Spring Public Forum, Dallas, TX, April 22, 2009.

178. Current Topics in General Surgery, "Surgery to Reduce the Risk of Breast Cancer", UT Southwestern Medical Center, Dallas, TX, April 30, 2009.


179. Eighth International Congress on the Future of Breast Cancer, Do Viruses Cause Breast Cancer, and Update on the Treatment of Breast Cancer in Men, Wailea, Maui, HI, July 2009.

180. Breast Cancer: From Prevention to Survivorship, Familial and Hereditary Cancer Risk: Surgical Options, Including Total Skin-Spring Mastectomy, Overland Park, KS, September 25, 2009.

181. New Developments in Breast Cancer, Integrating Advances in Surgical and Radiation Strategies to Optimize Local Control, Dallas, TX, September 26, 2009.

182. The Link Between Diet and Cancer-Can You Change Your Risk? KRLD’s Fifth Annual Breakthroughs in Medicine, Dallas, TX, October 3, 2009.

183. “Controversies in Surgery” and “Management of Male Breast Cancer”, Eighth Annual Controversies in Breast Cancer Adjuvant and Neoadjuvant Therapy, New York, NY, October 16-18, 2009.

184. Biology of Breast Carcinogenesis and Key Biologic Pathways, and Management of Rare and Male Breast Cancers and Benign Breast Conditions, 2009 School of Breast Oncology, Atlanta, GA, November 5-6, 2009.

185. New Developments in Breast Cancer, Integrating Advances in Surgical and Radiation Strategies to Optimize Local Control, Richmond, VA, November 14, 2009.

186. “Genetic Risk Assessment in Breast Cancer Patients: Impact on Increasing Prophylactic Mastectomies,” What’s New in Breast Reconstruction: Optimizing Results Using a Multi-Disciplinary Approach, Dallas, TX, December 5, 2009.

187. New Insights Into Surgical and Radiation Therapies, Current Trends in Breast Cancer, Dallas, TX, January 9, 2010.

188. Male Breast Cancer, 27th Annual Western Regional Oncology Conference, El Paso, TX,

January 23, 2010.

189. New Insights Into Surgical and Radiation Therapies, Current Trends in Breast Cancer, Pasadena, CA, January 30, 2010.

190. Tissue-based Breast Cancer Risk Stratification. Kansas City, MO, February 3, 2010.

191. Imaging and Local Therapy, Breast Cancer Highlights: Updates From the 2009 San

Antonio Breast Cancer Symposium, Kansas City, MO, February 4, 2010.

192. New Insights Into the Prevention and Treatment of Familial Breast Cancer, Society of Surgical Oncology 63rd Annual Cancer Symposium, St. Louis, MO, March 6-7, 2010.

193. Overview of Hereditary Cancer Genetics; Quantitative Risk Assessment: The Models; Challenging Cases/Ask the Experts. 20th Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 19-21, 2010.

194. From Radical Mastectomy to Conservative Therapy and Back, and Male Breast Cancer, 12th Annual Tyler Breast Cancer Conference, Tyler, TX, March 27, 2010.


195. Male Breast Cancer, 12th Annual Tyler Breast Cancer Conference, Tyler, TX, March 27, 2010.

196. Increasing Use of Bilateral Mastectomy: Is it Medically Indicated?, Massachusetts General Hospital, Boston, MA, June 15, 2010.

197. New Insights Into the Prevention and Management of Familial Breast Cancer, 9th International Congress on the Future of Breast Cancer, La Jolla, CA, July 24, 2010.

198. Rapid Reviews in Oncology: Update from the American Society for Clinical Oncology. Local and Regional Therapy. Telecasted Nationwide from Dallas, TX. July 27, 2010

199. Preventing and Managing Familial Breast Cancer, Controversies in Breast Cancer: Adjuvant & Neoadjuvant Therapy 2010, New York, NY, October 9, 2010.

200. No Boobs Allowed: Update on Cancer Genetic Syndromes and Management for Everything but HBOC, NSGC 29th Annual Education Conference, October 14, 2010.

201. Biology of Breast Carcinogenesis and Key Biologic Pathways, School of Breast Oncology, Atlanta, GA, November 11, 2010.

202. Management of Rare and Male Breast Cancers and Benign Breast Conditions, School of Breast Oncology, Atlanta, GA, November 12, 2010.

203. Rapid Reviews in Oncology: Update from the San Antonio Breast Cancer Symposium. Local and Regional Therapy. Telecasted Nationwide from Dallas, TX. December 15, 2010.

204. New Insights Into Local Control, Current Trends in Breast Cancer: Updates from the 2010 San Antonio Breast Cancer Symposium, Dallas, TX, January 15, 2011.

205. Preventing and Managing Breast Cancer in BRCA Gene Mutation Carriers, 28th Annual Western Regional Oncology Conference, El Paso, TX, January 22, 2011.

206. New Insights Into Local Control, Current Trends in Breast Cancer: Updates from the 2010 San Antonio Breast Cancer Symposium, Pasadena, CA, January 29, 2011.

207. Identifying Individuals with Genetic Susceptibility to Cancer, Society of Surgical Oncology’s 64th Annual Cancer Symposium, San Antonio, TX, March 5, 2011.

208. Overview of Hereditary Cancer Genetics; Quantitative Risk Assessment: Using Models, When and How, 21st Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 12, 2011.

209. Cancer Prevention: The Role of Nutrition and Physical Activity, Texas Medical Association Committee on Cancer, presented by the Physician Oncology Education Program, Houston, Texas, May 14, 2011.


210. Evaluation of a Collagen Based Breast Biopsy Marker (HydroMARK) as an Alternative to Wire and Radioactive Seed Localization for Non-Palpable Breast Lesions, 13th Annual UT Southwestern Department of Surgery Surgical Research Forum and The Dr. Robert S. Sparkman Lecture Series in Surgery, Dallas, TX, May 18, 2011.

211. Use of Adipose-Derived Stem Cells in Regenerative Therapy, Tenth International Congress on the Future of Breast Cancer, Coronado, CA, August 6, 2011.

212. Risk Assessment Models: Expanding Testing Indications, 2011 Breast Cancer Symposium, San Francisco, CA, September 8, 2011.



215. Management of the Axilla in Breast Cancer, 2012 29th Annual Western Regional Oncology Conference, El Paso, TX, January 21, 2012.

216. DCIS: Understanding & Managing Non-Invasive Breast Cancer, Annual (C4YW) Conference, New Orleans, Louisiana, February 26, 2012.

217. Panelist-Triple Negative path medicine, radiology, 22nd Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 12, 2012.

218. Clinical Management of High Risk Women with Heredity Breast Cancer, 22nd Annual National Interdisciplinary Breast Center Conference, Las Vegas, NV, March 13, 2012.

219. Use of Adipose Derived Stem Cell Generating Therapy and Management of Axilla in Breast cancer, Tyler Breast Conference, Saturday, March 24, 2012.

220. CME Short Course: Risk Modeling for Cancer Susceptibility Syndromes, 2012 American College of Medical Genetics, Charlotte, NC, March 27, 2012.

221. Energy Balance, UT Southwestern Plastic Surgery Event, Dallas, TX, April 28, 2012.

222. Teleconference Lecture, DCIS Research & Treatment Update, Living Beyond Breast Cancer, Thursday, May 17, 2012 – Noon-1:15 p.m.

223. Campus Conference, Paracrine and Endocrine Effects of Adipose Tissue on cancer development and progression. UT Southwestern Medical Center, Center for Human Nutrition, Clinical Research Conferences Group, June 18, 2012.

224. Presentation: “What Did IBCSG-23-01, ACOSOG Z-11, and NSABP-B32 Tell us about Dissection of the Axilla”. 11th International Congress on the Future of Breast Cancer, Coronado, CA, July 27, 2012.




227. “The Changing Role of Axillary Surgery in Breast Cancer”, Eleventh Annual Controversies in Breast Cancer Adjuvant and Neoadjuvant Therapy, New York, NY, November 16-18, 2012.

RESEARCH PRESENTATIONS AT NATIONAL MEETINGS 1. Hudd C, Euhus DM, La Regina MC, Herbold DR, Palmer DC, Johnson FE. Effect of

cholecystokinin on the metabolism and growth of human cholangiocarcinoma. Gastroenterology 1984;86(5):118.

2. Euhus DM, Gupta RK, Wong JH, Ramming KP, Morton DL. Effects of a melanoma cell

vaccine on the level of antibody to a tumor associated antigen in melanoma patients. 1987 Proc Amer Assoc Cancer Res 28; 349.

3. Gupta RK, Euhus DM, Morton DL. Detection of a tumor-associated antigen in the urine of

melanoma patients by allogeneic antibody. 1987 Fed Proc 46; 1059. 4. Euhus DM, Langsford C, Gupta RK, Wong JH, Morton DL. Measurement of a glycoprotein

tumor associated antigen (TAA) using antibodies of different isotypes from a melanoma patient. 1988 FASEB J 2(5); A1836.

5. Gupta RK, Wong JH, Euhus DM, Morton DL. Detection of tumor antigen specific immune

complexes in sera of melanoma patients and its relationship with disease recurrence. 1988 FASEB J 2(5); A1470.

6. Euhus DM, Gupta RK, Wong JH, Morton DL. Demonstration and isolation of a tumor

associated antigen from sera of melanoma patients. 1988 Proc Amer Soc Clin Oncol 7; 44. 7. Wong JH, Gupta RK, Huth JF, Euhus DM, Morton DL. Augmentation of anti-fetal antigen

antibody levels in melanoma patients undergoing active specific immunotherapy with a tumor cell vaccine. 1988 Proc Amer Soc Clin Oncol 7; 248.

8. Wong JH, Gupta RK, Euhus DM, Morton DL. 69.5 Kd glycoprotein fetal antigen tumor

marker in melanoma. 1988 Proc Amer Soc Clin Oncol 7; 252. 9. Gupta RK, Wong JH, Euhus DM, Ramming KP, Morton DL. Immunoprognostic

significance of tumor antigen specific immune complexes in melanoma patients. 1988 Proc Amer Assoc Cancer Res 29; 390.

10. Euhus DM, Gupta RK, Wong JH, Ramming KP, Morton DL. A murine monoclonal

antibody to a glycoprotein tumor associated antigen in sera and urine of melanoma patients. 1988 Proc Amer Assoc Cancer Res 29; 393.


11. Bauer RL, Kopald KH, Gupta RK, Euhus DM, Morton DL. Detection of tumor antigen containing immune complexes in sera of cancer patients. 1989 Proc Amer Assoc Cancer Res 30; 358.

12. Kopald KH, Bauer RL, Gupta RK, Euhus DM, Morton DL. Immunoprognostic significance

of a tumor associated antigen excreted in the urine of melanoma patients. 1989 Proc Amer Soc Clin Oncol 8; 290.

13. Euhus DM, O’Rourke S, Galea M, Ellis I, Elston C, Blamey R. The incidence and

prognosis of locally recurrent breast cancer is a function of the aggressiveness of the primary tumor. 1992 Proc Amer Soc Clin Oncol 11; 93.

14. Euhus, DM. Impact of a changing colonoscopy rate on the diagnosis and survival of

patients with colorectal cancer. 38th Parallel Med Soc Meeting. 1993. 15. Wilkinson NW, Molina B, Euhus D. Predicting the histology of suspicious mammographic

abnormalities: A multivariate analysis of historical and radiographic features. Gary Wratten Surgical Symposium. May 1994.

16. Euhus DM. High efficiency adenoviral-mediated gene transfer in human breast cancer cells.

Soc Surg Oncol, Boston, March 1995. 17. Euhus DM, Kimura L. Cytokine-mediated gene therapy of human breast cancer:

Characterization of tumor infiltrating lymphocytes (TIL) elaborated by transduced organoid cultures. Gary Wratten Surgical Symposium, Boston, May 1995.

18. Euhus DM, Kimura L. Characterization of lymphocytes infiltrating breast cancers and

surrounding normal breast tissue. Breast Cancer Res Treat 1995;37(suppl):109(#388). 19. Euhus DM, Wilkinson N, Molina B. Predicting the histology of suspicious mammographic

abnormalities. 18th Annual Breast Cancer Symposium, San Antonio, 1995. 20. Euhus DM, Kimura L, Arnold B. Activation of human lymphocytes cytotoxic for

autologous breast cells by interleukin-2 (IL-2) gene transfer. Soc Surg Oncol, Atlanta, 1996. 21. Wilkinson N, Arnold B, Euhus D. Metaplastic breast cancer: Characterization of an

immortal cell line. Gary Wratten Surgical Symposium, Denver, April 1996. 22. Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and

severity of mastodynia in premenopausal women: A multi-institutional cross-sectional study. Gary Wratten Surgical Symposium, Denver, April 1996.

23. Nelson J, Kimura, L, Euhus D. Cytokine gene based immunotherapy: Consequences of

bypassing T-helper function. Hawaiian Surgical Association, Maui, June 1996. 24. Nelson J, Kimura, L, Euhus D. Cytokine gene based immunotherapy: Consequences of

bypassing T-helper function. Society of University Surgeons, Milwaukee, Wisconsin, February 1998.

25. Nwariaku FE, Beitsch P, Clifford E, Euhus D, Leitch AM, Peters G. Accuracy of sentinel

lymph node biopsy for staging breast cancer. North Texas Chapter, American College of Surgeons. Dallas, TX, February 1998.


26. Euhus, DM, Tomlinson GE. Predicting BRCA1 mutation status. North Texas Chapter,

American College of Surgeons. Dallas, TX, February 1998. 27. Sakaguchi M, Virmani AK, Euhus D, Milchgrub S, Gazdar A. Molecular detection of

lymph node micrometastases of breast cancer by immunobeads enrichment abd RT-PCR. Am Assc Cancer Res, New Orleans, LA, March 1998.

28. Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and

severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study. Breast Dis: A Year Book Quarterly 1998;9:25.

29. Euhus DM, Peters GN, Leitch AM, Albores-Saavedra J, Mathews D, Erdman W, Anglin B,

Huth J. Primary tumor characteristics predicting unsuccessful mammary sentinel lymph node identification. Western Surgical Association November 1998; Indianapolis, IN.

30. Euhus D, Wistuba I, Albores-Saavedra J, Gazdar A. High frequency of loss of

heterozygosity at 3p in benign proliferative lesions preceding invasive breast cancer. Association for Academic Surgery November 1998; Seattle, WA.

31. Ar’Raja A, Euhus DM, Leitch AM, Erdman W, Mathews D, Saboorian H, Peters GN.

Subdermal versus intraparenchymal colloid injection for identifying mammary sentinel lymph nodes. North Texas Chapter American College of Surgeons. February 1999.

32. Euhus DM, Leitch AM, Huth J, Erdman W, Mathews D, Milchgrub S, Peters G. Hot, blue,

or hot and blue: Maximizing the accuracy of mammary sentinel lymph node (SLN) biopsy. Society of Surgical Oncology, March 1999; Orlando FL.

33. Erdman WA, Ar’Rajab A, Euhus DM, Leitch AM, Mathews D, Saboorian H, Peters GN.

Mammary lymphoscintigraphy: Do volume and injection site matter? 46th Ann Meeting Soc Nucl Med, 1999 Los Angeles, CA.

34. Scott DJ, Bergan PC, Euhus DM, Guo W, Jeyarajah DR, Laycock R, Rege RV, Tesfay ST,

Thompson WM, Valentine RJ. Intensive laparoscopic skills training improves operative performance of surgery residents. Surgical Forum, 1999.

35. Stukey A, Euhus D, Tomlinson G, Gazdar A, Minna J. Comprehensive allelotyping of

breast cancer cell lines detects chromosomal loss in 8p21-23. Surgical Forum, 1999. 36. Scott DJ, Bergen PC, Euhus DM, Guo WA, Jeyarajah DR, La R, Rege RV, Tesfay FT,

Thompson WM, Valentine RJ, Jones DB. Comparison of edited videotape to direct observation to assess operative performance after laparoscopic skills training. Association of Academic Surgeons, November 1999, Philadelphia, PA.

37. Euhus DM, Leitch AM, Huth JF, Peters GN. Implementing computer-based breast cancer

risk assessment in the clinic. Association of Academic Surgeons, November 1999, Philadelphia, PA.

38. Euhus DM, Peters GN, Leitch AM, Saboorian H, Mathews D, Erdman W, Huth J.

Validating the performance of the mammary sentinel lymph node team. San Antonio Breast Cancer Symposium, 1999.


39. Euhus DM, Milchgrub S, Shivapurkar N, Peters GN, Leitch AM, Alberts A, Gazdar AF. Increased microsatellite abnormalities in breast epithelial cells from women at increased risk for breast cancer. San Antonio Breast Cancer Symposium 1999.

40. Euhus DM, Shivapurkar N, Milchgrub S, Peters GN, Leitch AM, Gazdar AF. Microsatellite

changes at chromosome 4q in benign breast epithelium from women at high risk for breast cancer. Am Soc Clin Oncol. New Orleans, LA, June 2000.

41. Peterson D, Tebas P, Picker L, Powderly W, Pitcher C, Stiffler L, Quittner C, Euhus D,

Lisziewicz J, Mauney J, Stevens M, Grosso R. Naive and memory cell production in zidovudine and stavudine treated subjects: START I and II Immunology Substudy. 13TH International AIDS Conference Durban, South Africa, July 9-14, 2000.

42. Euhus D, Shivapurkar N, Milchrub S, Peters GN, Leitch AM, Richey AR, Gazdar AF.

Molecular approaches to breast cancer risk assessment. Early Detection Research Network Investigators Meeting, Chicago, September 2000.

43. Euhus D, Shivapurkar N, Milchrub S, Peters GN, Leitch AM, Richey AR, Gazdar AF.

Prevalence of genetic instability in breast epithelium from asymptomatic risk-defined women. Symposium on Impact of Biotechnology on Cancer Diagnostic and Prognostic Indicators. Geneva, Switzerland, October 2000.

44. Smith K, Tomlinson G, Robinson L, Stucky A, Olopade O, Cummings S, Garber J,

Chittendon A, Mills G, Rieger P, Esserman L, Crawford B, Hughes K, Roche C, Ganz P, Seldon J, Fabian C, Klemp J, Euhus D. Accuracy of risk counselors and a computer model (BRCAPRO) for identifying women likely to carry BRCA gene mutations. Natl Soc Genetic Counselors, Savannah, Georgia, November 2000.

45. Euhus DM, Shivapurkar N, Milchgrub S, Richey AR, Peters GN, Leitch AM, Gazdar AF.

Microsatellite DNA changes at chromosome 4 in benign breast epithelium from risk-defined women. Assc Academ Surg, Tampa FL, November 2000.

46. Dooley WC, Veronesi U, Elledge R, O’Shaughnessy J, Ljung B-M … Euhus, DM, et al.

Detection of pre-malignant and malignant breast cells by ductal lavage. 23rd Annual San Antonio Breast Cancer Symposium, San Antonio, TX (Abstr 17), 12/2000.

47. Dudak M, Sakaguchi S, Gazdar A, Peters G, Leitch AM, Euhus DM. Clinical relevance of

RT-PCR in the evaluation of the mammary sentinel lymph node: correlation with primary tumor characteristics and outcome. Society of Surgical Oncology, 54th Annual Cancer Symposium, Washington, DC, March 2001.

48. Peters G, Fodera T, Sabol J, Jones S, Euhus D. Estrogen replacement therapy after breast

cancer: A 12-year follow-up. Society of Surgical Oncology, 54th Annual Cancer Symposium, Washington, DC, March 2001.

49. Euhus DM, Smith KC, Robinson L, Stukey FA, Olopade OI, Cummings S, Garber JE,

Chitendon A, Mills GB, Reiger P, Esserman L, Crawford B, Hughes KS, Roche C, Ganz P, Seldon J, Fabian CJ, Klemp J, Tomlinson G. Brcapro Enhances The Performance Of Risk Counselors For Differentiating BRCA Gene Mutation Carriers From Non-Carrriers Based On Nuclear Pedigree Information. Am Soc Clin Oncol, San Francisco, CA, 2001.


50. Epker J, Barfoot B, Crossland J, Robinson R, Euhus D, Maddrey AM. Patients at risk for breast cancer: Biopsychosocial functioning. Ann Behavioral Med 2001;23 (suppl):S071.

51. Euhus D, Zochbauer-Muller S, Lewis C, Gazdar A, Minna J. Promoter region

hypermethylation of tumor suppressor genes in benign breast epithelium from asymptomatic risk-defined women. Association Academic Surgeons, Milwaukee, WI, 2001.

52. Euhus D, Aragaki C, Hughes KS, Haley RW, Lowry WS, Cann J, Elliott T, Tomlinson G.

Ethnic differences in breast cancer incidence and mortality in Bermuda. Soc Surg Oncol, Denver, CO, March 2002.

53. Akkanti BH, Naftalis EZ, Chacko C, Peters GN, Leitch AM, Euhus DM. Histopathological

markers predicting positive resection margins in breast conserving surgery. Soc Surg Oncol, Denver, CO, March 2002.

54. Berry MP, Parsons WC, Tomlinson G, Peters GN, Euhus DM. Mammographic density in

BRCA1 gene mutation carriers. Soc Surg Oncol, Denver, CO, March 2002. 55. Schroen AT, Euhus DM, Peters GN, Chacko C, Leitch AM. Internal mammary lymph node

biopsy: Value in accurate prognostic staging. Soc Surg Oncol, Denver, CO, March 2002. 56. Hoover SJ, Leitch AM, Euhus DM, Peters GN. Role of sentinel lymph node biopsy in

ductal carcinoma in situ and ductal carcinoma in situ with microinvasion. Soc Surg Oncol, Denver, CO, March 2002.

57. Lewis CM, Zochbauer-Muller S, Cler, LR, Minna JD, Euhus DM. Potential role of

promoter region hypermethylation of RASSF1A, APC, H-Cadherin or Cyclin D2 for breast cancer risk assessment. American Association for Cancer Research, San Francisco, CA, April 2002.

58. Bu D, Cler LR, Lewis CM, Minna JD, Euhus DM. A variant of DNA polymerase β is not

cancer-specific. American Association for Cancer Research, San Francisco, CA, April 2002. 59. Euhus DM, Ashfaq R, Milchgrub S, Naftalis E, Leitch AM, Virmani A. Comparison of

Nipple Duct Lavage & Random Fine Needle Aspiration Biopsy for the Detection of Atypical Breast Epithelium. Soc Surg Oncol, Los Angeles, CA, March 2003.

60. Bu D, Lewis CM, Cler L, Elias K, Milchgrub S, Minna J, Euhus DM. Comparative Real

Time PCR for the Detection of c-Myc, Cyclin D1 and Her-2/neu Gene Amplification in Breast Fine Needle Aspirates. American Association for Cancer Research, Washington, DC, July 2003.

61. Tomlinson GE, Schorge J, Robinson L, Patterson A, Okupa A, Davis H, Haley B, Naftalis E,

Leitch AM, Euhus DM. Risk Reduction Practices after BRCA1 BRCA2 Testing. American Society of Clinical Oncology, Chicago, IL, June 2003.

62. Cler LR, Ashfaq R, Naftalis E, Leitch AM, Hoover S, Euhus DM Cytological atypia

diagnosed by nipple duct lavage: reproducibility and MRI findings. Association of Academic Surgery, Sacramento, CA, November 2003.


63. Lewis, C, Cler LR, Bu D, Zochbauer-Muller S, Milchgrub S, Naftalis E, Minna JD, Euhus DM. Promoter Hypermethylation of RASSF1A and APC Correlate with Predicted Gail Model Breast Cancer Risk, Keystone, CO, 2003.

64. Johnson A, Ashfaq R, Cler L, Naftalis E, Leitch AM, Hoover S, Euhus DM. Cytological

Atypia Diagnosed by Nipple Duct Lavage: Reproducibility and MRI Findings. Soc Surg Oncology, New York, NY, March 2004.

65. Bu D, Tomlinson G, Lewis C, Cler L, Kildebeck E, Euhus D. DNA repair gene

polymorphisms in breast cancer patients unlikely to carry BRCA gene mutations. American Association for Cancer Research’s 95th Annual Meeting, Orlando, FL, March 29, 2004.

66. Johnson A, Ashfaq R, Naftalis E, Leitch AM, Hoover S, Euhus DM. Patient and Duct

Selection for Nipple Duct Lavage: Challenging the Current Paradigm. American Society of Breast Surgeons, Las Vegas, NV, April 2004.

67. Zhou C, Naftalis E, Chao J, Euhus D, Adams Jr. W, Kenkel J, Schorge J, Muller C.

Feasibility and Cost-Effectiveness of Combined Bilateral Mastectomy and Reconstruction with Bilater Oophorectomy. The Center for Breast Care, UT Southwestern Medical Center at Dallas, Dallas, TX. January 20, 2004. 28th Annual Symposium of the ASBD, Boston, MA. April 2004.

68. Lewis C, Cler L, Bu D, Zochbauer-Muller S, Milchgrub S, Naftalis E, Leitch M, Minna J,

Euhus D. Promoter Hypermethylation in Benign Breast Epithelium in relation to Predicted Breast Cancer Risk. American Association for Cancer Research, Seattle, WA., Oct 2004.

69. Herbert B, Lewis C, Shay J, Euhus D. Establishment of an Immortalized Breast Epithelial

Cell Line Derived from a Germ-line BRCA2 Mutation Carrier. American Association for Cancer Research, San Francisco, CA., Nov. 2004.

70. McWhite K, Evans P, Wynn R, Leitch AM, Huth J, Euhus D. Efficacy of Ultrasound Guided

Core Biopsy for the Preoperative Assessment of Axillary Lymph Nodes. Society of Surgical Oncology, Atlanta, GA., March 2005.

71. Sanderson DM, Euhus D, Huth JF, Hoover SJ, Leitch AM. Outcomes in Sentinel Lymph

Node Negative Patients without Axillary Dissection. Society of Surgical Oncology, Atlanta, GA, March 2005.

72. Coyle Y, Euhus D, Hynan L, Minna J. Effect of Physical Activity on Epigenetic Markers for

Breast Cancer. American Association for Cancer Research, Anaheim, CA. April 2005. 73. Lewis C, Herbert B, Bu D, Holloway S, Beck A, Ashfaq R, Shay J, Euhus D. Establishment

and Characterization of a Breast Epithelial Cell Line Derived from a Germ-line BRCA2 Mutation Carrier. American Association for Cancer Research, Anaheim, CA. April 2005.

74. Bu D, Lewis C, Euhus D. Single Nucleotide Polymorphisms in DNA Base Excision Repair

Genes in Relation to Breast Cancer Risk. American Association for Cancer Research, Anaheim, CA. April 2005.

75. Euhus D, Ashfaq R, Bu D, Leitch AM, Lewis C. Assessment of tumor suppressor gene

methylation for breast cancer risk screening. American Society of Clinical Oncology, Atlanta, GA. June 2006.


76. Euhus D. Methylation markers common to breast and lung cancer segregate with breast

cancer risk in benign breast epithelial cells obtained by periareolar fine needle aspiration (FNA). San Antonio Breast Cancer Symposium, San Antonio, TX. December 2006.

77. Ma AM, Euhus D. Comparison of cell yield and cytology for nipple ductal lavage and

random periareolar fine needle aspiration biopsies performed in the same patients. Soc Surg Oncol 2007.

78. Lewis C, Bu D, Euhus D. Promoter methylation in nipple duct lavage and fine needle

aspiration in relation to breast cancer risk. American Association for Cancer Research, Los Angeles, CA. April 2007.

79. Ma AM, Bowling M, Leitch M, Rao R, Euhus DM. Primary breast tumor characteristics

predicting aggressive nodal involvement. Amer Soc Breast Surg, Phoenix, AZ, May, 2007. 80. Bowling M, Ma AM, Rao R, Leitch AM, Euhus DM. Comparison of Outcomes of

Metaplastic Carcinoma treated by Partial Mastectomy (PM) vs. Total Mastectomy (TM). Amer Soc Breast Surg, Phoenix, AZ, May, 2007.

81. Euhus DM, Bu D, Milchgrub S, Xie X-J, Bian A, Leich AM, Lewis CM. Cell-based Breast

Cancer Risk Stratification based on DNA Methylation in Fine Needle Aspiration Samples. Am Soc Clin Oncol June, 2007.

82. Ma AM, Euhus D. Comparison of cell yield and cytology for nipple ductal lavage and

random periareolar fine needle aspiration biopsies performed in the same patients. Am Soc Clin Oncol, Breast 2007.

83. Bowling M, Ma AM, Rao R, Leitch AM, Euhus DM. Comparison of Outcomes of

Metaplastic Carcinoma Treated by Partial Mastectomy (PM) vs. Total Mastectomy (TM). Am Soc Clin Oncol, Breast 2007.

84. Lewis CM, Bu D, Ashfaq R, Xie X-J, Miller A, Dooley W, O’Shaughnessy J, Arun B, Hunt

K, Euhus DM. Tamoxifen modulates tumor suppressor gene methylation in breast cells and growth factors in plasma in women at increased risk for breast cancer. American Association for Cancer Research, Frontiers in Cancer Prevention Research, November 2007, B32.

85. Moldrem A, Ulissey M, Lewis C, Bu D, Ashfaq R, Sarode V, Xie X, Hunt K,

O’Shaughnessy J, Miller A, Dooley W, Euhus D. The Biology of Mammographic Density in High Risk Women, Short: Biology of Mammographic Density, Society of Surgical Oncology, Annual Cancer Symposium, Chicago, IL, March 2008.

86. Menendez C, Moldrem A, Leitch A, Evans P, Euhus D. The Effect of Preoperative Breast MRI on

the Surgical Management of Breast Cancer - Does It Offer a Benefit? American Society of Breast Disease, 32nd Annual Symposium, San Diego, CA, April 2008.

87. Euhus DM, Bu D, Ashfaq R, Xie X-J, Bian A, Leitch AM, Lewis CM. Atypia and DNA methylation

in nipple duct lavage in relation to predicted breast cancer risk. DoD Era of Hope, Baltimore, MD, June 2008.

88. Lewis CM, Bu D, Euhus DM. Obesity, insulin resistance and oxidative stress: implication for breast carcinogenesis. San Antonio Breast Cancer Symposium, San Antonio, TX, December 2008.


89. Lewis CM, Bu D, Euhus DM. Promoter methylation biomarkers for breast cancer risk stratification

using an unbiased whole genome approach. American Association for Cancer Research. Washington DC, 2010.

90. Hill V, Hesson L, Dansranjavin T, Dallol A, Bieche I, Tommasi S, Dobbins T, Gentle D, Euhus D, Dammann R, Ward R, Minna J, Maher ER, Pfeifer G, Latif F. MIRA (methylated CpG island recovery assay) assay identifies frequently methylated genes in breast cancer. American Association of Cancer Research. Washington DC, April 2010.

91. Euhus, D, Bu,D-W, Ashfaq, R, Lewis, C End Organ Effects of Positive Energy Balance in

the Breast, AICR Conference, Washington, DC, October 20-22, 2010.

92. Euhus, DM, Bu D-w, Chin M, Ashfaq R, Lewis, CM, Epigenetic Markers for Tissue-Based Breast Cancer Risk Stratification, Frontiers in Cancer Prevention, Philadelphia, PA, November 7-9, 2010.

93. JA Mook MD, HA Hamann PhD, A Moldrem MD, AM Leitch MD, R Rao MD, V Anderews MD, R Klein MD, L Robinson, E Brown, J Morrow, E Euhus, MD. BRCA Gene Mutation Testing and UpTake of Risk Management Recommendations in a Minority Under-Insured Population. North Texas Chapter of American College of Surgeons 2011 Annual Meeting, February 19, 2011.

94. JA Mook MD, R Klein MD, AM Leitch MD, A Moldrem MD, D Euhus MD, V Andrews

MD, V Sarode MD, Y Peng MD, R Rao MD. Routine Cavity Shave Margin Excision Reduces Total Volume of Tissue Removed in Partial Mastectomy for Breast Cancer. North Texas Chapter of American College of Surgeons 2011 Annual Meeting, February, 19, 2011.

95. RL Klein MD, JA Mook MD, D Euhus MD, R Rao MD, R Wynn MD, M Leitch MD.

Evaluation of a Collagen Based Breast Biopsy Marker (Hydromark) as an Alternative to Wire and Radioactive Seed Localization for Non-Palpable Breast Lesions. North Texas Chapter of American College of Surgeons 2011 Annual Meeting, February, 19, 2011.

96. Amy Brazda MD, Jordan Estroff MD, David Euhus MD, A. Marilyn Leitch MD, James Huth

MD, Valerie Andrews MD, Amy Moldrem MD, Roshni Rao, MD. Delays in Tim to Treatment and Survival Impact in Breast Cancer, 13th Annual UT Southwestern Department of Surgery Surgical Research Forum and The Dr. Robert S. Sparkman Lecture Series in Surgery, Dallas, TX, May 18, 2011.

97. Julie Mook MD, Rebecca Klein MD, Valerie Andrews MD, David Euhus MD, Marilyn

Leitch MD, Amy Moldrem MD, Yan Peng MD, Venetia Sarode MD, Roshni Rao MD. Routine Cavity Shave Margin Excision Reduces Total Volume of Tissue Removed in Partial Mastectomy for Breast Cancer, 13th Annual UT Southwestern Department of Surgery Surgical Research Forum and The Dr. Robert S. Sparkman Lecture Series in Surgery, Dallas, TX, May 18, 2011.

98. Cho HS, Davis GC, Paek JE, Rao R, Zhao H, Xie XJ, Yousef MG, Fedric T, Euhus, DH, Leitch M. A randomized trial of nursing interventions supporting recovery of the


postmastectomy patient. J Clin Nurs.2012 Jul 25. Doi: 101111/J1365-2702.04100.x. PMID: 22830927

Documents

David M. Euhus, M.D. · Recertified October 19, 2001 and December 16, 2010 (Valid until July 1, 2022) Certificate # 037077 . MILITARY . Department of Surgery Tripler Army Medical